Physician profile
Horace E Deal
NPI 1851373567
$3,366.76
in general payments reported to CMS, 2019-2025
18 companies · $459 in 2025
The $459 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $744 · 2020: $266 · 2021: $603 · 2022: $321 · 2023: $261 · 2024: $713 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,432.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $911.96 | 2019-2025 | Total30, Precision7, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $417.16 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $334.63 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $326.87 | 2022-2025 | Infuse, Miebo, Xiidra |
| Novartis Pharmaceuticals Corporation | $189.06 | 2021-2022 | |
| Glaukos Corporation | $181.86 | 2024 | Idose |
| Maculogix, INC. | $156.24 | 2021 | |
| Optos, INC. | $148.88 | 2019-2020 | |
| Coopervision INC. | $138.84 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Biotissue Holdings INC. | $125.85 | 2020-2024 | |
| Rxsight INC | $115.68 | 2025 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Sun Pharmaceutical Industries INC. | $106.99 | 2023-2025 | Cequa |
| Shire North American Group INC | $80.96 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $44.64 | 2024 | Xdemvy |
| Lombart Brothers, INC. | $40.00 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Eyevance Pharmaceuticals LLC | $15.09 | 2020 | |
| Oyster Point Pharma, INC. | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Horace Deal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.